Profile data is unavailable for this security.
About the company
Cutia Therapeutics is an investment holding company principally engaged in the dermatology biopharmaceutical business. The Company is dedicated to developing solutions in the dermatology treatment and care market, including scalp diseases and care, skin diseases and care, topical anesthesia and localized adipose accumulation management. The Company is primarily engaged in the distribution of scalp diseases and care products, as well as certain skin care products. The Company's principal pipeline products include topical finasteride spray CU-40102, topical 4% minocycline foam CU-10201, topical novel small molecule agent CU-10101, localized topical lidocaine and tetracaine cream CU-30101 and recombinant mutant collagenase CU-20401.
- Revenue in HKD (TTM)283.11m
- Net income in HKD-534.12m
- Incorporated2019
- Employees298.00
- LocationCutia Therapeutics436 Heng Feng RoadJingan District, 20/F, Huanzhi BuildingSHANGHAI ChinaCHN
- Websitehttps://www.cutiatx.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Meilleure Health Intrntnl Indu Grp Ltd | 38.10m | 39.17m | 968.96m | 49.00 | 24.69 | 0.7958 | -- | 25.43 | 0.0096 | 0.0096 | 0.0093 | 0.2978 | 0.0223 | 0.0363 | 0.9608 | 828,173.90 | 2.28 | 2.74 | 2.60 | 3.02 | 72.64 | 47.18 | 102.27 | 28.59 | 2.39 | -- | 0.2211 | 41.83 | -60.81 | -26.41 | -20.45 | -- | -1.03 | -- |
| Transcenta Holding Ltd | 10.64m | -301.23m | 1.06bn | 171.00 | -- | 1.31 | -- | 99.79 | -0.7435 | -0.7435 | 0.0262 | 1.80 | 0.0075 | 0.3793 | 0.4927 | 57,826.02 | -21.21 | -32.48 | -30.08 | -41.13 | 34.76 | 22.08 | -2,831.15 | -1,072.37 | 0.4387 | -408.75 | 0.2437 | -- | -79.09 | -23.91 | 37.24 | -- | -60.12 | -- |
| 3D Medicines Inc | 507.11m | -190.57m | 1.09bn | 183.00 | -- | 1.35 | -- | 2.16 | -0.7779 | -0.7779 | 2.07 | 3.14 | 0.3728 | 7.53 | 6.78 | 2,655,023.00 | -14.79 | -- | -21.47 | -- | 92.11 | -- | -39.68 | -- | 1.59 | -- | 0.205 | -- | -29.81 | -- | 65.19 | -- | -- | -- |
| Jilin Provnc Hnn Chnglng Bio-pharm CoLtd | 1.05bn | 206.93m | 1.15bn | 798.00 | 5.58 | 0.589 | 4.80 | 1.10 | 0.3694 | 0.3694 | 1.87 | 3.50 | 0.3698 | 2.30 | 3.34 | 1,407,136.00 | 7.30 | 7.46 | 10.54 | 10.45 | 78.95 | 77.80 | 19.74 | 20.45 | 1.42 | -- | 0.0422 | 44.00 | 4.71 | 6.41 | 24.32 | 4.95 | -8.31 | -- |
| Beijing Biostar Pharmaceuticals Co Ltd | -100.00bn | -100.00bn | 1.35bn | 147.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 7.85 | -- | 24.19 | -- | -- | -- |
| Dawnrays Pharmaceutical (Holdings) Ltd | 1.26bn | 199.57m | 1.77bn | 1.12k | 8.90 | 0.4748 | 6.00 | 1.41 | 0.1326 | 0.1326 | 0.8359 | 2.49 | 0.2809 | 2.47 | 7.96 | 1,064,304.00 | 4.36 | 10.98 | 5.07 | 13.75 | 45.76 | 55.52 | 15.53 | 32.76 | 4.21 | -- | 0.0028 | 31.01 | -7.89 | 2.22 | 73.29 | 17.20 | 17.13 | 2.69 |
| Cutia Therapeutics | 283.11m | -534.12m | 1.83bn | 298.00 | -- | 1.89 | -- | 6.47 | -1.70 | -1.70 | 0.901 | 2.67 | 0.1908 | 2.55 | 5.57 | 850,183.20 | -36.00 | -- | -44.42 | -- | 34.92 | -- | -188.66 | -- | 2.92 | -- | 0.2774 | -- | 103.17 | -- | 77.91 | -- | -- | -- |
| Zhaoke Ophthalmology Ltd | 39.99m | -314.76m | 1.90bn | 270.00 | -- | 0.9794 | -- | 47.41 | -0.5689 | -0.5689 | 0.0724 | 3.53 | 0.0159 | 1.38 | 9.25 | 136,014.20 | -12.50 | -38.02 | -14.65 | -41.79 | 49.28 | -- | -787.13 | -4,412.89 | 4.36 | -29.83 | 0.1373 | -- | 269.73 | -- | 38.32 | -- | 18.80 | -- |
| Jbm (Healthcare) Ltd | 812.98m | 216.39m | 2.24bn | 412.00 | 10.24 | 2.08 | 8.06 | 2.75 | 0.2657 | 0.2657 | 0.9984 | 1.31 | 0.5111 | 3.76 | 5.05 | 2,913,918.00 | 14.09 | 6.57 | 17.00 | 7.83 | 56.76 | 47.82 | 27.56 | 16.60 | 2.41 | -- | 0.2486 | 53.40 | 20.65 | 15.44 | 51.20 | 36.90 | 35.96 | -- |
| Golden Throat Holdings Group Co Ltd | 1.11bn | 303.22m | 2.34bn | 842.00 | 7.70 | 1.71 | 6.85 | 2.11 | 0.4101 | 0.4101 | 1.50 | 1.85 | 0.467 | 2.29 | 5.32 | 1,267,739.00 | 12.78 | 11.71 | 21.02 | 16.75 | 76.42 | 73.08 | 27.37 | 25.87 | 1.73 | 21.95 | 0.3616 | 94.67 | 23.26 | 8.25 | 27.37 | 13.71 | -12.27 | 34.38 |
| Hangzhou Jiuyuan Genetic Biopharm Co Ltd | 1.48bn | 139.59m | 2.35bn | 1.63k | 15.06 | 1.32 | 12.62 | 1.59 | 0.6462 | 0.6462 | 7.23 | 7.36 | 0.7509 | 1.55 | 2.17 | 958,190.90 | 7.10 | -- | 8.88 | -- | 81.67 | -- | 9.45 | -- | 4.03 | 46.31 | 0.1058 | -- | 6.35 | -- | 15.72 | -- | -- | -- |
| SinoMab Bioscience Ltd | 0.00 | -163.24m | 2.48bn | 61.00 | -- | 7.84 | -- | -- | -0.1508 | -0.1508 | 0.00 | 0.2284 | 0.00 | -- | -- | 0.00 | -18.46 | -22.26 | -24.62 | -25.68 | -- | -- | -- | -3,832.94 | -- | -7.82 | 0.6265 | -- | 48.42 | -- | 23.85 | -- | -0.376 | -- |
| Essex Bio-Technology Ltd | 1.73bn | 313.18m | 2.51bn | 1.43k | 8.02 | 1.10 | 6.76 | 1.44 | 0.5508 | 0.5508 | 3.05 | 4.01 | 0.5596 | 2.96 | 2.84 | 1,196,360.00 | 10.10 | 10.28 | 13.56 | 13.62 | 89.50 | 87.73 | 18.05 | 18.70 | 1.82 | -- | 0.1135 | 17.49 | -3.87 | 5.47 | 11.61 | 0.3101 | -7.47 | 7.14 |
| Jacobson Pharma Corporation Ltd | 1.53bn | 302.58m | 2.54bn | 1.79k | 8.36 | 1.14 | 5.63 | 1.66 | 0.1519 | 0.1519 | 0.7698 | 1.12 | 0.4299 | 2.54 | 9.06 | 876,757.00 | 8.48 | 4.83 | 10.29 | 6.17 | 44.30 | 41.26 | 19.73 | 14.85 | 0.9023 | 10.21 | 0.286 | 57.09 | 7.43 | 0.0691 | 43.09 | 7.05 | 24.09 | 14.87 |
Data as of Feb 13 2026. Currency figures normalised to Cutia Therapeutics's reporting currency: Hong Kong Dollar HKD
4.27%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| FIL Investment Management (Hong Kong) Ltd.as of 31 Dec 2025 | 15.20m | 4.17% |
| Dimensional Fund Advisors LPas of 30 Nov 2025 | 372.40k | 0.10% |
| FIL Investment Advisors (UK) Ltd.as of 31 Oct 2023 | 1.00 | 0.00% |
| E Fund Management Co., Ltd.as of 30 Jun 2025 | 0.00 | 0.00% |
| Bosera Asset Management Co., Ltd.as of 30 Jun 2025 | 0.00 | 0.00% |
| Harvest Fund Management Co., Ltd.as of 30 Jun 2025 | 0.00 | 0.00% |
More ▼
Data from 30 Jun 2025 - 05 Feb 2026Source: FactSet Research Systems Inc.
